The clinical efficacy and safety of anlotinib and albumin-bound paclitaxel as the third-line therapy in patients with non-small cell lung cancer cancer

ZHAO Zilong, ZHANG Meiyun, GAO Hui, DU Wei, BA Yaer, LYU Yihua△

Tianjin Medical Journal . 2022, (5): 539 -543 . DOI: 10.11958/20212207